RALIQRY
Live / Registered — Registered (as of 07 Jan 2025)
What this means for you
Registered since 07 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98432033
- Registration number
- 7641957
- Mark type
- Stylized text
- Filed
- 04 Mar 2024
- Published for opposition
- 19 Nov 2024
- Registered
- 07 Jan 2025
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
Owner
- GLAXO GROUP LIMITED, Stevenage, GB
- GLAXO GROUP LIMITED, Stevenage, GB
- GLAXO GROUP LIMITED, Stevenage, GB
Prosecution history
- 07 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 19 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Nov 2024 — PUBLISHED FOR OPPOSITION
- 13 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Oct 2024 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 19 Sept 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 19 Sept 2024 — LETTER OF SUSPENSION E-MAILED
- 19 Sept 2024 — SUSPENSION LETTER WRITTEN
- 18 Sept 2024 — ASSIGNED TO EXAMINER
- 04 Mar 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Mar 2024 — NEW APPLICATION ENTERED